Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MK0476 [montelukast] phase II/III placebo controlled double blind study.

Trial Profile

MK0476 [montelukast] phase II/III placebo controlled double blind study.

Phase of Trial: Phase III

Latest Information Update: 15 Jul 2014

At a glance

  • Drugs Montelukast (Primary)
  • Indications Acute asthma
  • Focus Therapeutic Use
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 01 Aug 2012 Results published in the Journal of Asthma.
    • 01 Aug 2012 Patient numbers changed from 225 to 242 as stated in the published article
    • 24 Mar 2009 Trial phase changed from II/III to III as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top